The regulation of the endosomal compartment by p53 the tumor suppressor gene

FEBS Journal

Volumn 276, Issue 8, 2009, Pages 2201-2212

  Yu, Xin ^b   Riley, Todd ^a,c   Levine, Arnold J ^a,b  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

EGF receptor; Endosomal compartment; Exosome production; Internalization; P53 regulation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; CELL DIVISION; CELL GROWTH; CELL INTERACTION; CELL MEMBRANE; CELL STRESS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENDOSOME; GENE CONTROL; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL MEMBRANE; ENDOSOMES; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; VESICULAR TRANSPORT PROTEINS;

EID: 63049113332     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06949.x     Document Type: Article

References (44)

1. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323 331.
2. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S Levine AJ (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67, 3043 3053.
3. Feng Z, Zhang H, Levine AJ Jin S (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102, 8204 8209.
4. Levine AJ, Feng Z, Mak TW, You H Jin S (2006) Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 20, 267 275.
5. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F Hwang PM (2006) p53 regulates mitochondrial respiration. Science 312, 1650 1653.
6. Margulies L Sehgal PB (1993) Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J Biol Chem 268, 15096 15100.
7. Dijsselbloem N, Goriely S, Albarani V, Gerlo S, Francoz S, Marine JC, Goldman M, Haegeman G Vanden Berghe W (2007) A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J Immunol 178, 5048 5057.
8. Secchiero P, Corallini F, Rimondi E, Chiaruttini C, di Iasio MG, Rustighi A, Del Sal G Zauli G (2008) Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Blood 111, 1287 1294.
9. Krizhanovsky V, Xue W, Zender L, Yon M, Hernando E Lowe SW (2009) Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol, doi :.
10. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657 667.
11. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656 660.
12. Yu X, Harris SL Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66, 4795 4801.
13. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113, 3365 3374.
14. Fevrier B Raposo G (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16, 415 421.
15. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B, Amson R Telerman A (2004) TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem 279, 46104 46112.
16. Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L et al. (2003) The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA 100, 2284 2289.
17. Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, Vidal M, Amson R Telerman A (2008) Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 15, 1723 1733.
18. Sendamarai AK, Ohgami RS, Fleming MD Lawrence CM (2008) Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle. Proc Natl Acad Sci USA 105, 7410 7415.
19. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE Fleming MD (2005) Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37, 1264 1269.
20. Woodman P (2009) ESCRT proteins, endosome organization and mitogenic receptor down-regulation. Biochem Soc Trans 37, 146 150.
21. Saksena S, Sun J, Chu T Emr SD (2007) ESCRTing proteins in the endocytic pathway. Trends Biochem Sci 32, 561 573.
22. Morita E Sundquist WI (2004) Retrovirus budding. Annu Rev Cell Dev Biol 20, 395 425.
23. Slagsvold T, Pattni K, Malerod L Stenmark H (2006) Endosomal and non-endosomal functions of ESCRT proteins. Trends Cell Biol 16, 317 326.
24. van der Goot FG Gruenberg J (2006) Intra-endosomal membrane traffic. Trends Cell Biol 16, 514 521.
25. Le Roy C Wrana JL (2005) Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6, 112 126.
26. Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG Lisanti MP (2006) Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Res 66, 10647 10651.
27. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG Lisanti MP (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279, 51630 51646.
28. Lavie Y, Fiucci G Liscovitch M (2001) Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev 49, 317 323.
29. Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI Shariat SF (2007) Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67, 614 622.
30. Liedtke C, Kersting C, Burger H, Kiesel L Wulfing P (2007) Caveolin-1 expression in benign and malignant lesions of the breast. World J Surg Oncol 5, 110.
31. Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, James M, Hornick JL, Pereira EM, Milanezi F et al. (2007) Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 13, 90 101.
32. Aguilar RC Wendland B (2005) Endocytosis of membrane receptors: two pathways are better than one. Proc Natl Acad Sci USA 102, 2679 2680.
33. Razani B, Woodman SE Lisanti MP (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54, 431 467.
34. Bist A, Fielding CJ Fielding PE (2000) p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry 39, 1966 1972.
35. Bist A, Fielding PE Fielding CJ (1997) Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 94, 10693 10698.
36. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW Vogelstein B (1999) Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 96, 14517 14522.
37. Hoh J, Jin S, Parrado T, Edington J, Levine AJ Ott J (2002) The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 99, 8467 8472.
38. Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M Stanimirovic D (2004) Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene 23, 6967 6979.
39. Gu D, Li H, Wang Z, Chen Q, Jiang J Zhu H (2007) Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway. Laryngoscope 117, 1782 1789.
40. Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM Paller AS (2007) Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res 67, 9986 9995.
41. Harris SL Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899 2908.
42. Pochampally R, Fodera B, Chen L, Lu W Chen J (1999) Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem 274, 15271 15277.
43. Chen X, Ko LJ, Jayaraman L Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10, 2438 2451.
44. Lin J, Chen J, Elenbaas B Levine AJ (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev 8, 1235 1246.